Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$15.25 CAD
Change Today 0.00 / 0.00%
Volume 0.0
NDQ On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ GM
As of 3:59 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

novadaq technologies inc (NDQ) Snapshot

Open
C$14.56
Previous Close
C$15.25
Day High
C$15.25
Day Low
C$14.16
52 Week High
04/15/15 - C$21.50
52 Week Low
10/17/14 - C$11.68
Market Cap
856.8M
Average Volume 10 Days
2.5K
EPS TTM
C$-0.55
Shares Outstanding
56.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NOVADAQ TECHNOLOGIES INC (NDQ)

Related News

No related news articles were found.

novadaq technologies inc (NDQ) Related Businessweek News

No Related Businessweek News Found

novadaq technologies inc (NDQ) Details

Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging products for use by surgeons in the operating room and other clinical settings in the United States and internationally. Its proprietary imaging platform is used to visualize blood vessels, nerves, and the lymphatic system during surgical procedures. The company offers SPY Elite imaging system for use in coronary artery bypass, cardiovascular, plastic, reconstructive, micro, organ transplant, and gastrointestinal surgeries; and PINPOINT endoscopic fluorescence imaging system used for traditional endoscope and to obtain fluorescence images on demand or in a simultaneous imaging mode during minimally invasive surgery. It also provides Firefly imaging systems for use in robotic surgery; LUNA fluorescence angiography that enables clinicians to visually assess tissue perfusion in a various cardiovascular procedures; CO2 heart laser system for transmyocardial revascularization; and DermACELL tissue products for use in breast reconstruction surgeries, as well as in the treatment of chronic non-healing wounds. In addition, the company markets SPY Analysis Toolkit, a post-processing software that allows physicians to enhance and apply objective analysis tools to SPY Elite and LUNA images. Novadaq Technologies Inc. was founded in 2000 and is headquartered in Mississauga, Canada.

215 Employees
Last Reported Date: 02/26/15
Founded in 2000

novadaq technologies inc (NDQ) Top Compensated Officers

Chairman of The Board, Chief Executive Office...
Total Annual Compensation: $390.2K
Co-Founder, Senior Vice President and General...
Total Annual Compensation: $222.7K
Chief Financial Officer
Total Annual Compensation: $206.4K
Vice President of Marketing
Total Annual Compensation: $175.0K
Compensation as of Fiscal Year 2014.

novadaq technologies inc (NDQ) Key Developments

Novadaq Technologies Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Revised Revenue Guidance for the Year Ending December 31, 2015

Novadaq Technologies Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, total revenue was $15,066,427 compared to $11,152,156 a year ago. Loss from operations was $12,394,436 compared to $4,570,706 a year ago. Loss before income taxes was $6,025,908 compared to profit before income tax of $6,282,558 a year ago. Net loss was $6,025,908 compared to net profit of $6,282,558 a year ago. The net loss was a result of an increase in operating expenses of $11.6 million and a decrease in warrant revaluation income of $4.5 million. Cash used in operating activities was $7,745,578 compared to $7,614,364 a year ago. Purchase of property and equipment amounted to $1,629,522 compared to $2,025,681 a year ago. For the six months, total revenue was $26,757,768 compared to $21,450,378 a year ago. Loss from operations was $23,730,151 compared to $8,816,935 a year ago. Loss before income taxes was $17,311,299 compared to $9,814,209 a year ago. Net loss was $17,311,299 compared to $9,830,351 a year ago. Cash used in operating activities was $16,353,181 compared to $11,339,114 a year ago. Purchase of property and equipment amounted to $2,835,621 compared to $4,316,388 a year ago. Previously the company anticipated its full year revenue for the fiscal year ending December 31, 2015 to be approximately $65.0 million, representing total year-over-year revenue growth of approximately 40%. This was based on the company’s expectation that growth in the first half of 2015 would be in the range of 25% to 35%. Given that actual growth in the first half of 2015 came in at the low end of that range, the company is revising its 2015 outlook and now expects its full-year revenue to be approximately $62.5 million. This implies a growth rate of 43% over the second half of 2014.

Novadaq Technologies Inc. to Report Q2, 2015 Results on Jul 28, 2015

Novadaq Technologies Inc. announced that they will report Q2, 2015 results at 4:30 PM, US Eastern Standard Time on Jul 28, 2015

Novadaq Technologies Inc., Q2 2015 Earnings Call, Jul 28, 2015

Novadaq Technologies Inc., Q2 2015 Earnings Call, Jul 28, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NDQ:CN C$15.25 CAD 0.00

NDQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CryoLife Inc $11.01 USD 0.00
View Industry Companies
 

Industry Analysis

NDQ

Industry Average

Valuation NDQ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.7x
Price/Book 4.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVADAQ TECHNOLOGIES INC, please visit www.novadaq.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.